Position in NVS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$406,218
+$56 QoQ
Shares Held
2,592
-2.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#988
of 1,603 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Key Financial Inc holds $18,745,925 across 16 Drug Manufacturers - General names. NVS ranks #10 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
25,096 | $6,373,630 | |
| 2 | ABBV |
AbbVie Inc.
|
16,434 | $4,135,451 | |
| 3 | MRK |
Merck & Co., Inc.
|
22,676 | $2,913,866 | |
| 4 | PFE |
Pfizer Inc
|
52,416 | $1,262,176 | |
| 5 | LLY |
ELI LILLY & Co
|
824 | $988,330 | |
| 6 | AZN |
Astrazeneca PLC
|
4,187 | $793,938 | |
| 7 | AMGN |
Amgen Inc
|
1,527 | $552,957 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,257 | $537,829 |
All Filings in NVS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $406,218 | 2,592 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $406,162 | 2,659 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $357,359 | 2,592 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $332,398 | 2,592 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $313,657 | 2,592 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $288,956 | 2,592 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $303,217 | 3,116 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $358,402 | 3,116 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $334,284 | 3,140 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $303,732 | 3,140 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $317,045 | 3,140 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $301,403 | 2,959 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $298,592 | 2,959 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $263,028 | 2,859 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $168,648 | 1,859 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $141,302 | 1,859 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $157,141 | 1,859 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $163,127 | 1,859 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $75,136 | 859 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $70,249 | 859 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $78,375 | 859 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $73,427 | 859 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $81,115 | 859 | Shares | Sole | 2021-01-29 | |
| 2020-03-31 | $78,162 | 948 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||